Preclinical and clinical phase I studies of a new recombinant Filgrastim (BK0023) in comparison with Neupogen(®)

BACKGROUND: Filgrastim or methionyl-granulocyte colony-stimulating factor (Met-G-CSF), is a recombinant therapeutic protein widely used to treat severe neutropenia caused by myelosuppressive drugs in patients with nonmyeloid malignancies. In addition to its role in the regulation of granulopoiesis,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Crobu, Davide, Spinetti, Gaia, Schrepfer, Rodolfo, Tonon, Giancarlo, Jotti, Gloria Saccani, Onali, Pierluigi, Dedoni, Simona, Orsini, Gaetano, Di Stefano, Andrea
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3942296/
https://ncbi.nlm.nih.gov/pubmed/24555723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-6511-15-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados